These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25581106)

  • 1. Drugs for chronic heart failure.
    Med Lett Drugs Ther; 2015 Jan; 57(1460):9-13. PubMed ID: 25581106
    [No Abstract]   [Full Text] [Related]  

  • 2. What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Tajik AA; Dickstein K
    Heart; 2016 Dec; 102(23):1922-1932. PubMed ID: 27742799
    [No Abstract]   [Full Text] [Related]  

  • 3. Ivabradine and outcomes in chronic heart failure.
    Gupta A; Sharma YP
    Lancet; 2010 Dec; 376(9758):2069; author reply 2069-70. PubMed ID: 21168044
    [No Abstract]   [Full Text] [Related]  

  • 4. Crunch time for heart failure care in England and Wales.
    Lancet; 2010 Dec; 376(9758):2041. PubMed ID: 21168037
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of chronic heart failure.
    Packer M
    Lancet; 1992 Jul; 340(8811):92-5. PubMed ID: 1352023
    [No Abstract]   [Full Text] [Related]  

  • 6. MY APPROACH to the patient with heart failure and improved ejection fraction
    Cohn JN
    Trends Cardiovasc Med; 2018 Feb; 28(2):153. PubMed ID: 29032935
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological management of chronic heart failure: old drugs, new drugs and new indications.
    Lim WY; Woldman S
    Br J Hosp Med (Lond); 2013 Feb; 74(2):C18-22. PubMed ID: 23411909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacotherapy in HFrEF].
    Güder G; Frantz S
    Dtsch Med Wochenschr; 2020 Sep; 145(19):1384-1390. PubMed ID: 32971553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments.
    Naegele M; Flammer AJ; Enseleit F; Ruschitzka F
    Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
    Lumbers RT; Martin N; Manoharan K; Thomas J; Davies LC
    Heart; 2019 Oct; 105(20):1533-1535. PubMed ID: 31345952
    [No Abstract]   [Full Text] [Related]  

  • 11. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey.
    Komajda M; Anker SD; Cowie MR; Filippatos GS; Mengelle B; Ponikowski P; Tavazzi L;
    Eur J Heart Fail; 2016 May; 18(5):514-22. PubMed ID: 27095461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapies in chronic heart failure: a focus on reduced ejection fraction.
    Bolam H; Morton G; Kalra PR
    Clin Med (Lond); 2018 Mar; 18(2):138-145. PubMed ID: 29626018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study.
    Störk S; Hense HW; Zentgraf C; Uebelacker I; Jahns R; Ertl G; Angermann CE
    Eur J Heart Fail; 2008 Dec; 10(12):1236-45. PubMed ID: 18996739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic heart failure].
    Nowak B
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():76-80; quiz 81. PubMed ID: 24734463
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of chronic heart failure: an old disease with a new face.
    Prendergast HM; Bunney EB
    Emerg Med Australas; 2005 Apr; 17(2):143-51. PubMed ID: 15796729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of heart failure and preserved systolic function].
    Dahlström U; Boman K; Brodin LA; Hagerman I; Willenheimer R
    Lakartidningen; 2007 Aug 22-28; 104(34):2348-50. PubMed ID: 17907560
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of congestive heart failure. Has the time come for decreased complexity?
    Rydén L; Remme WJ
    Eur Heart J; 1999 Jun; 20(12):867-71. PubMed ID: 10329091
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on the 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure.
    Sionis A; ; Sionis Green A; Manito Lorite N; Bueno H; Coca Payeras A; Díaz Molina B; González Juanatey JR; Ruilope Urioste LM; Zamorano Gómez JL; ; Almenar Bonet L; Ariza Solé A; Bover Freire R; Lambert Rodríguez JL; López de Sá E; López Fernández S; Martín Asenjo R; Mirabet Pérez S; Pascual Figal D; Segovia Cubero J; Varela Román A; ; San Román Calvar JA; Alfonso Manterola F; Arribas Ynsaurriaga F; Evangelista Masip A; Ferreira González I; Jiménez Navarro M; Marin Ortuño F; Pérez de Isla L; Rodríguez Padial L; Sánchez Fernández PL; Sionis Green A; Vázquez García R
    Rev Esp Cardiol (Engl Ed); 2016 Dec; 69(12):1119-1125. PubMed ID: 27894486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.